- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
AbbVie Inc. $ABBV is BDF Gestion's 10th Largest Position
Institutional investor BDF Gestion increased its stake in pharmaceutical company AbbVie during Q4 2025.
Mar. 24, 2026 at 8:22am
Got story updates? Submit your updates here. ›
According to a recent SEC filing, investment firm BDF Gestion grew its holdings in AbbVie Inc. (NYSE:ABBV) by 28.9% during the fourth quarter of 2025. BDF Gestion now owns 44,504 shares of the pharmaceutical company's stock, making AbbVie its 10th largest holding and accounting for approximately 1.2% of the firm's total portfolio.
Why it matters
The increased stake in AbbVie by BDF Gestion, a prominent institutional investor, signals continued confidence in the pharmaceutical company's growth prospects and ability to generate returns for shareholders. AbbVie's diverse product portfolio and pipeline of new therapies have made it an attractive investment for many institutional funds.
The details
BDF Gestion purchased an additional 9,982 shares of AbbVie during the fourth quarter, bringing its total position to 44,504 shares valued at $10,169,000 as of the most recent SEC filing. The investment firm's increased allocation to AbbVie reflects the stock's strong performance and the company's strategic positioning within the pharmaceutical industry.
- BDF Gestion disclosed its increased AbbVie holdings in a Q4 2025 SEC filing.
The players
BDF Gestion
A prominent institutional investment firm that has made AbbVie one of its top 10 portfolio holdings.
AbbVie Inc.
A global biopharmaceutical company focused on developing innovative therapies for complex and chronic medical conditions.
The takeaway
BDF Gestion's increased stake in AbbVie underscores the pharmaceutical company's appeal as an investment amid its diverse product portfolio, robust pipeline, and strong financial performance. This move by a major institutional investor signals continued confidence in AbbVie's long-term growth prospects.
